Belshe RB - Search Results

1

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys.

Hall SL, Stokes A, Tierney EL, London WT, Belshe RB, Newman FC, Murphy BR. Hall SL, et al. Among authors: belshe rb. Virus Res. 1992 Mar;22(3):173-84. doi: 10.1016/0168-1702(92)90049-f. Virus Res. 1992. PMID: 1320790

2

Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.

Clements ML, Belshe RB, King J, Newman F, Westblom TU, Tierney EL, London WT, Murphy BR. Clements ML, et al. Among authors: belshe rb. J Clin Microbiol. 1991 Jun;29(6):1175-82. doi: 10.1128/jcm.29.6.1175-1182.1991. J Clin Microbiol. 1991. PMID: 1650789 Free PMC article.

3

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children.

Belshe RB, Karron RA, Newman FK, Anderson EL, Nugent SL, Steinhoff M, Clements ML, Wilson MH, Hall SL, Tierney EL, et al. Belshe RB, et al. J Clin Microbiol. 1992 Aug;30(8):2064-70. doi: 10.1128/jcm.30.8.2064-2070.1992. J Clin Microbiol. 1992. PMID: 1323576 Free PMC article. Clinical Trial.

4

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.

Karron RA, Belshe RB, Wright PF, Thumar B, Burns B, Newman F, Cannon JC, Thompson J, Tsai T, Paschalis M, Wu SL, Mitcho Y, Hackell J, Murphy BR, Tatem JM. Karron RA, et al. Among authors: belshe rb. Pediatr Infect Dis J. 2003 May;22(5):394-405. doi: 10.1097/01.inf.0000066244.31769.83. Pediatr Infect Dis J. 2003. PMID: 12792378 Clinical Trial.

5

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

Belshe RB, Newman FK, Tsai TF, Karron RA, Reisinger K, Roberton D, Marshall H, Schwartz R, King J, Henderson FW, Rodriguez W, Severs JM, Wright PF, Keyserling H, Weinberg GA, Bromberg K, Loh R, Sly P, McIntyre P, Ziegler JB, Hackell J, Deatly A, Georgiu A, Paschalis M, Wu SL, Tatem JM, Murphy B, Anderson E. Belshe RB, et al. J Infect Dis. 2004 Feb 1;189(3):462-70. doi: 10.1086/381184. Epub 2004 Jan 20. J Infect Dis. 2004. PMID: 14745704 Clinical Trial.

6

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers.

Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F, Blackburn N, Murphy BR, Belshe RB, Karron RA, Deatly AM, Gruber WC, Bernstein DI, Wright PF. Madhi SA, et al. Among authors: belshe rb. Vaccine. 2006 Mar 20;24(13):2432-9. doi: 10.1016/j.vaccine.2005.12.002. Epub 2005 Dec 20. Vaccine. 2006. PMID: 16406170 Clinical Trial.

7

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M. Treanor JJ, et al. Vaccine. 1999 Dec 10;18(9-10):899-906. doi: 10.1016/s0264-410x(99)00334-5. Vaccine. 1999. PMID: 10580204 Free article. Clinical Trial.

8

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR. Wright PF, et al. Among authors: belshe rb. J Infect Dis. 2000 Nov;182(5):1331-42. doi: 10.1086/315859. Epub 2000 Sep 22. J Infect Dis. 2000. PMID: 11010838

9

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.

Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, Gruber W, Murphy BR, Collins PL. Karron RA, et al. Among authors: belshe rb. J Infect Dis. 2005 Apr 1;191(7):1093-104. doi: 10.1086/427813. Epub 2005 Mar 1. J Infect Dis. 2005. PMID: 15747245 Clinical Trial.

10

Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection.

Belshe RB, Richardson LS, London WT, Sly DL, Camargo E, Prevar DA, Chanock RM. Belshe RB, et al. J Med Virol. 1978;3(2):101-10. doi: 10.1002/jmv.1890030203. J Med Virol. 1978. PMID: 104003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page